These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2835245)

  • 21. Early clinical experience with the novel NMDA receptor antagonist CNS 5161.
    Walters MR; Bradford AP; Fischer J; Lees KR
    Br J Clin Pharmacol; 2002 Mar; 53(3):305-11. PubMed ID: 11874394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man.
    Depré M; Margolskee DJ; Hsieh JY; Van Hecken A; Buntinx A; De Lepeleire I; Rogers JD; De Schepper PJ
    Eur J Clin Pharmacol; 1992; 43(4):427-30. PubMed ID: 1451725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist.
    Jones TR; Young R; Champion E; Charette L; Denis D; Ford-Hutchinson AW; Frenette R; Gauthier JY; Guindon Y; Kakushima M
    Can J Physiol Pharmacol; 1986 Aug; 64(8):1068-75. PubMed ID: 3024787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel arylthio- and arylsulfonylpropyloxyacetophenones: design and synthesis of L-648,051 and L-649,923, potent antagonists of leukotriene D4.
    Young RN; Jones TR; Atkinson JG; Bélanger P; Champion E; Denis D; DeHaven RN; Ford-Hutchinson AW; Fortin R; Frenette R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():544-8. PubMed ID: 2959111
    [No Abstract]   [Full Text] [Related]  

  • 27. The physiological disposition of aerosolized 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate (L-648,051) in rats.
    Tocco DJ; Duncan AE; deLuna FA; Wells G
    Drug Metab Dispos; 1988; 16(5):697-700. PubMed ID: 2906592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single oral dose safety, tolerability, and pharmacokinetics of PNU-96391 in healthy volunteers.
    Rodríguez CA; Azie NE; Adams G; Donaldson K; Francom SF; Staton BA; Bombardt PA
    J Clin Pharmacol; 2004 Mar; 44(3):276-83. PubMed ID: 14973308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First Clinical Experience with ONO-4232: A Randomized, Double-blind, Placebo-controlled Healthy Volunteer Study of a Novel Lusitropic Agent for Acutely Decompensated Heart Failure.
    Ward CL; Jamieson V; Nabata T; Sharpe J; Dozono K; Suto F; Hashimoto Y; Gussak I
    Clin Ther; 2016 May; 38(5):1109-21. PubMed ID: 27001444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-participation of thromboxane A2 and leukotriene C4 and D4 in mediating cyclosporine-induced acute renal failure.
    Perico N; Pasini M; Gaspari F; Abbate M; Remuzzi G
    Transplantation; 1991 Nov; 52(5):873-8. PubMed ID: 1835198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
    Mong S; Wu HL; Miller J; Hall RF; Gleason JG; Crooke ST
    Mol Pharmacol; 1987 Aug; 32(1):223-9. PubMed ID: 3039338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers.
    Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
    Clin Ther; 2016 Jan; 38(1):53-65. PubMed ID: 26718605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma.
    Britton JR; Hanley SP; Tattersfield AE
    J Allergy Clin Immunol; 1987 May; 79(5):811-6. PubMed ID: 3571772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukotriene receptor antagonists. 4. Synthesis and leukotriene D4/E4 receptor antagonist activity of 4-(alkyl)acetophenone derivatives.
    Gapinski DM; Roman CR; Rinkema LE; Fleisch JH
    J Med Chem; 1988 Jan; 31(1):172-5. PubMed ID: 2826785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4.
    Buckner CK; Krell RD; Laravuso RB; Coursin DB; Bernstein PR; Will JA
    J Pharmacol Exp Ther; 1986 May; 237(2):558-62. PubMed ID: 3009792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.
    Kips JC; Joos GF; De Lepeleire I; Margolskee DJ; Buntinx A; Pauwels RA; Van der Straeten ME
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):617-21. PubMed ID: 1892302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukotriene D4-induced homologous desensitization of calcium mobilization in rat basophilic leukemia cells.
    Winkler JD; Mong S; Crooke ST
    J Pharmacol Exp Ther; 1988 Feb; 244(2):449-55. PubMed ID: 2831340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma.
    Fowler A; Koenen R; Hilbert J; Blatchford J; Kappeler D; Benediktus E; Wood C; Gupta A
    J Clin Pharmacol; 2017 Nov; 57(11):1444-1453. PubMed ID: 28609567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A long-acting pegylated recombinant human growth hormone (Jintrolong
    Guan Y; He F; Wu J; Zhao L; Wang X; Huang L; Zeng G; Ren B; Chen J; Liao X; Ma Z; Chen X; Zhong G; Huang M; Zhao X
    J Clin Pharm Ther; 2018 Oct; 43(5):640-646. PubMed ID: 29959799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.